Atrosab

N/A

Report date: 2024/01/08 10:25:14

Base Information

Drug NameAtrosab
Drug Alias Nameatrosab-MSAnti-TNF-receptor-1 monoclonal antibody
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-Tumor necrosis factor receptor superfamily member 1A
TargetsTumor necrosis factor receptor superfamily member 1A
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCelonic
China Registration ClassN/A

Develop Information

Active CompaniesBaliopharm Ag
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A